10-Q: Elite Health Systems Q3 Loss Widens Amid Medicare Advantage Push

Elite Health Systems Inc. reported a widened net loss in Q3 2025 as it continues to invest heavily in its new Medicare Advantage plan business, with revenue generation expected in January 2026.

Summary

• Reported a net loss of $1,161,000 for the three months ended September 30, 2025, compared to a net loss of $290,000 for the same period in 2024.
• For the nine months ended September 30, 2025, the net loss was $2,026,000, up from $1,034,000 in the prior year period.
• Selling, general, and administrative expenses increased by 201% to $1,165,000 for the three months and 57% to $2,036,000 for the nine months, primarily due to start-up costs for Elite Health Plan and non-cash compensation.
• The company has no revenue as it is in the pre-operational phase for its Medicare Advantage plans, with significant revenue generation anticipated from January 2026.
• Elite Health Plan received a Knox-Keene license in California in May 2025 and conditional CMS approval for its CY 2026 Medicare Advantage/Prescription Drug application in June 2025.
• Marketing and member onboarding for the California Medicare Advantage plan began in October 2025.
• Stockholders approved the acquisition of Physician Support Systems, Inc. (PSS) on October 31, 2025, which closed on November 1, 2025, through the issuance of 3,158,000 common shares.
• A private placement initiated in July 2025, targeting $2,000,000 to $5,000,000 at $0.95 per share, raised $1,890,000 by September 30, 2025, and exceeded $3,000,000 by the filing date.
• The CEO concluded that disclosure controls and procedures were not effective as of September 30, 2025, due to a material weakness in internal control over financial reporting related to insufficient qualified personnel.

Sentiment

Score: 3

Explanation: While the company has made progress in licensing and strategic acquisitions for its new business, the significant increase in losses, zero revenue, ongoing cash burn, and identified material weakness in internal controls present substantial financial and operational challenges. The 'going concern' doubt remains a major concern, despite management's optimistic outlook on future capital raises.

Positives

• Received Knox-Keene license in California in May 2025, a critical regulatory approval for operating managed health care plans.
• Obtained conditional CMS approval and executed a contract for its CY 2026 Medicare Advantage/Prescription Drug application in June 2025.
• Successfully commenced marketing and member onboarding for its California Medicare Advantage plan in October 2025.
• Completed the acquisition of Physician Support Systems, Inc. (PSS) on November 1, 2025, which is expected to contribute revenue from January 2026.
• Successfully raised over $3,000,000 in a private placement by the filing date, demonstrating continued investor support for its new business direction.
• Secured a $2,500,000 Note and Line of Credit for Elite Health Plan, Inc. to meet tangible net equity requirements for licensure.

Negatives

• Reported a significantly widened net loss of $1,161,000 for Q3 2025, a 201% increase from $290,000 in Q3 2024.
• Accumulated deficit increased to $6,471,000 at September 30, 2025, from $4,445,000 at December 31, 2024.
• Operating expenses (selling, general, and administrative) increased substantially by 57% for the nine months ended September 30, 2025, to $2,036,000, driven by start-up costs.
• The company currently generates no revenue, relying entirely on capital raises to fund operations.
• Net cash used in operating activities increased to $1,448,000 for the nine months ended September 30, 2025, from $988,000 in the prior year, indicating increased cash burn.
• The CEO concluded that disclosure controls and procedures were not effective as of September 30, 2025, due to a material weakness in internal control over financial reporting.
• Substantial doubt exists regarding the company's ability to continue as a going concern due to recurring losses, accumulated deficit, and reliance on future capital raises.

Risks

• Uncertainties relating to the ability to successfully implement the strategy of developing a Medicare Advantage plan under Elite Health subsidiaries.
• Uncertainty over the ability to maintain a Medicare Advantage license in California, acquire managed health consumers in California, expand consumer enrollment beyond this initial state, or diversify and expand the portfolio of products and services, which would significantly impair business and results of operations.
• Ability to successfully integrate the operations of PSS and other potential future acquisitions.
• Ability to raise capital in the future on satisfactory terms.
• Financial condition and liquidity.
• Uncertainty over the ability to successfully implement management's plan to improve liquidity, including the ability to manage costs, systems, and growth.
• Operating in a highly competitive and rapidly changing environment.
• Dependence on the ability to achieve profitability, increase revenues, sustain current operations, maintain satisfactory relations with business partners, attract and retain key personnel, maintain and expand strategic alliances, and protect intellectual property.
• Increased interest rates, construction delays, economic slowdowns, and changes in plans could adversely affect the overall financial strategy.

Future Outlook

The company expects to begin generating significant revenue from its Medicare Advantage Plan in January 2026, following the commencement of marketing and member onboarding in California in October 2025 and the acquisition of Physician Support Systems, Inc. on November 1, 2025. Management believes it will be successful in raising additional capital in 2026 and managing expenses to continue as a going concern through at least the next twelve months. The company also plans to apply for a Medicare Advantage license in Nevada.

Management Comments

• Management believes its plan alleviates the substantial doubt and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months.
• The Company believes it will be successful in raising additional capital in 2026.
• The Company believes that these activities and resulting expenses can be managed to the level of cash resources on hand and expected to be raised.
• The Company has determined that its best opportunity for long term success is to concentrate its efforts and resources on establishing a managed care organization that will develop and operate Medicare Advantage plans for, and provide related health services to, seniors in California and other areas in the U.S.

Industry Context

Elite Health Systems is transitioning into the highly competitive Medicare Advantage market, a segment of healthcare experiencing significant growth due to the aging U.S. population. The company's strategy to focus on California and Nevada, coupled with the acquisition of a practice management company (PSS), aims to build a comprehensive managed care organization. Success will depend on its ability to establish provider networks, enroll members, and efficiently deliver quality services, aligning with broader industry trends towards integrated care and value-based models.

Comparison to Industry Standards

• NA The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks. The company is in a pre-revenue, start-up phase for its new core business.

Corporate Governance

Related Party Transactions

• Stock grants were recorded as compensation to directors and officers for the years ended December 31, 2024, and 2025. For 2025, this included 40,000 shares each for directors St. Lawrence and Leimkuhler, 75,000 for the Executive Director, and 375,000 for CEO and Board Chair, Dr. Jeereddi (issued August 2025, valued at $0.95/share). For 2024, this included 75,000 shares each for directors St. Lawrence and Leimkuhler, 75,000 for the Executive Director, and 250,000 for CEO and Board Chair, Dr. Jeereddi (issued January 2025, valued at $0.50/share).
• The acquisition of Physician Support Systems, Inc. (PSS) involves related parties: Dr. Prasad Jeereddi (CEO) owns 46% of PSS, Dr. Praveena Jeereddi (CEO's daughter) owns 44%, and the Executive Director of Elite Health Plan owns 10%.
• Elite Health Plan, Inc. entered into a $2,500,000 Note and Line of Credit with Rao R. Yalamanchili on April 25, 2025.

Stakeholder Impact

• Shareholders face significant dilution from ongoing stock issuances for capital raises and compensation. While there is potential for future value if the Medicare Advantage strategy succeeds, there is substantial risk due to current losses and going concern doubt.
• Future employees in the new Medicare Advantage business could see growth opportunities, but current operational losses and reliance on capital raises introduce uncertainty.
• Future customers (Medicare Advantage members) in California and Nevada may benefit from new healthcare options.
• Creditors, particularly those related to the $2,500,000 Line of Credit, have their rights subordinated to all present and future creditors of Elite Health Plan, Inc., which could impact recovery in case of default.

Next Steps

• Complete the second private offering, expected in November 2025.
• Begin generating significant revenue from the Medicare Advantage Plan in January 2026.
• Continue establishing a sufficient network of providers and enrolling a critical level of subscribers for the Medicare Advantage plan.
• Apply for a license to operate a Medicare Advantage plan in Nevada.
• Successfully integrate the operations of Physician Support Systems, Inc. (PSS).
• Raise additional capital in 2026.
• Manage activities and expenses to align with cash resources.

Key Dates

Recommendation

The company is in a highly speculative pre-revenue phase for its new core business, marked by significantly increasing net losses and a substantial accumulated deficit. While it has secured necessary licenses and is actively raising capital, the explicit 'substantial doubt regarding the Company's ability to continue as a going concern' is a critical red flag. The identified material weakness in internal controls further exacerbates concerns about financial reporting reliability. Despite strategic progress in licensing and acquisitions, the lack of current revenue, high cash burn, and reliance on future capital raises make this a high-risk investment with significant downside potential. A seasoned investor would likely avoid or sell given the fundamental financial weaknesses and going concern risk.

Keywords

Medicare Advantage, Health Systems, Managed Care, SEC Filing, 10-Q, Elite Health Systems, Healthcare, Financial Report, California, Nevada, Physician Support Systems, Capital Raise, Going Concern, Internal Controls